Literature DB >> 15622544

Capillary physiology and drug delivery in central nervous system lymphomas.

Peter C Warnke1, Jens Timmer, Christoph B Ostertag, Klaus Kopitzki.   

Abstract

To evaluate whether the chemosensitivity of primary central nervous system lymphomas to water-soluble drugs could result from improved drug delivery, we quantitatively assessed pharmacokinetic factors in seven patients. The capillary permeability surface product was found to be significantly increased in central nervous system lymphomas compared with glioblastoma multiforme, medulloblastomas, and metastases. Tumoral blood flow was significantly greater than in normal white matter. Our results suggest favorable pharmacokinetics to water- and lipid-soluble drugs in primary central nervous system lymphomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15622544     DOI: 10.1002/ana.20335

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

Review 1.  Permeability imaging in pediatric brain tumors.

Authors:  Sandi Lam; Yimo Lin; Peter C Warnke
Journal:  Transl Pediatr       Date:  2014-07

2.  Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI.

Authors:  Koung Mi Kang; Seung Hong Choi; Park Chul-Kee; Tae Min Kim; Sung-Hye Park; Joo Ho Lee; Soon-Tae Lee; Inpyeong Hwang; Roh-Eul Yoo; Tae Jin Yun; Ji-Hoon Kim; Chul-Ho Sohn
Journal:  Eur Radiol       Date:  2021-05-18       Impact factor: 5.315

3.  Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction.

Authors:  C H Toh; K-C Wei; C-N Chang; S-H Ng; H-F Wong
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-24       Impact factor: 3.825

4.  Evaluation of microvascular permeability with dynamic contrast-enhanced MRI for the differentiation of primary CNS lymphoma and glioblastoma: radiologic-pathologic correlation.

Authors:  P Kickingereder; F Sahm; B Wiestler; M Roethke; S Heiland; H-P Schlemmer; W Wick; A von Deimling; M Bendszus; A Radbruch
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-10       Impact factor: 3.825

5.  Phase II trial of intratumoral BCNU injection and radiotherapy on untreated adult malignant glioma.

Authors:  Michael D Jenkinson; Trevor S Smith; Brian Haylock; David Husband; Aditya Shenoy; Sobhan Vinjamuri; Carol Walker; Denis Pietronigro; Peter C Warnke
Journal:  J Neurooncol       Date:  2010-01-10       Impact factor: 4.130

6.  Diagnostic Accuracy of T1-Weighted Dynamic Contrast-Enhanced-MRI and DWI-ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma.

Authors:  X Lin; M Lee; O Buck; K M Woo; Z Zhang; V Hatzoglou; A Omuro; J Arevalo-Perez; A A Thomas; J Huse; K Peck; A I Holodny; R J Young
Journal:  AJNR Am J Neuroradiol       Date:  2016-12-08       Impact factor: 3.825

7.  Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms.

Authors:  C Walker; B Haylock; D Husband; K A Joyce; D Fildes; M D Jenkinson; T Smith; J Broome; K Kopitzki; D G du Plessis; J Prosser; S Vinjamuri; P C Warnke
Journal:  Br J Cancer       Date:  2006-10-10       Impact factor: 7.640

Review 8.  Hemodynamic Imaging in Cerebral Diffuse Glioma-Part A: Concept, Differential Diagnosis and Tumor Grading.

Authors:  Lelio Guida; Vittorio Stumpo; Jacopo Bellomo; Christiaan Hendrik Bas van Niftrik; Martina Sebök; Moncef Berhouma; Andrea Bink; Michael Weller; Zsolt Kulcsar; Luca Regli; Jorn Fierstra
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.